Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

Faster, Cleaner, Better.

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
options
options strategies
company

Dynamic Pharmaceuticals Invesco ETF (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Quote Overview for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

[[ rowChartData.labelLow ]]

[[ rowChartData.lowPriceFormatted ]]

[[ rowChartData.lowPrice ]]

[[ rowChartData.labelHigh ]]

[[ rowChartData.highPriceFormatted ]]

[[ rowChartData.highPrice ]]

since [[ rowChartData.lowDate ]]

since [[ rowChartData.highDate ]]

[[ value ]] [[ value ]]

Full Chart

Realtime quote and/or trades are not sourced from all markets.

Fund Basics

Fund Family Invesco
Assets Under Management 309,108,800
Shares Outstanding, K 2,860
60-Month Beta 0.50

Price/Earnings ttm 15.19
Annual Dividend & Yield 1.02 (0.95%)
Most Recent Dividend 0.246 on 12/22/25
Management Fee 0.56%
INDUSTRY GROUPING:
ETFs - Biotech

Options Overview Details

View History

Implied Volatility 37.74% (+7.93%)
Historical Volatility 13.31%
IV Percentile 87%
IV Rank 85.11%
IV High 41.97% on 04/09/25
IV Low 13.51% on 02/21/25
Expected Move (DTE 22) 0.00 (0.00%)

Put/Call Vol Ratio 999.99
Today's Volume 1
Volume Avg (30-Day) 0
Put/Call OI Ratio 0.29
Today's Open Interest 36
Open Int (30-Day) 33
Expected Range 108.08 to 108.08

Price Performance

Period	Period Low	Period High	Performance
1-Month	103.79 +4.13% on 12/02/25	108.40 -0.30% on 12/24/25	+3.11 (+2.96%) since 11/24/25
3-Month	90.01 +20.08% on 09/25/25	108.40 -0.30% on 12/24/25	+16.52 (+18.05%) since 09/24/25
52-Week	72.25 +49.59% on 04/09/25	108.40 -0.30% on 12/24/25	+25.08 (+30.21%) since 12/24/24

Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News

Is Wall Street Bullish or Bearish on Gilead Sciences Stock? Barchart - Fri Oct 31, 4:44AM CDT

Gilead Sciences has outpaced the broader market over the past year, and analysts maintain a fairly bullish outlook on the stock’s future performance.

Pfizer Stock: Is Wall Street Bullish or Bearish? Barchart - Wed Oct 29, 8:27AM CDT

Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Abbvie Inc HQ photo-by vzphotos via iStock

AbbVie Stock Outlook: Is Wall Street Bullish or Bearish? Barchart - Tue Aug 5, 7:57AM CDT

Despite AbbVie’s underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Are Wall Street Analysts Bullish on Gilead Sciences Stock? Barchart - Thu Jul 31, 8:52AM CDT

Gilead Sciences has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Pfizer Stock: Analyst Estimates & Ratings Barchart - Tue Jul 29, 8:58AM CDT

Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the stock’s future performance.

AMGEN Inc_ HQ sign- by JHVEPhoto via iStock

How Is Amgen's Stock Performance Compared to Other Pharmaceuticals Stocks? Barchart - Mon Jun 9, 8:01AM CDT

Amgen has underperformed the Pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

Abbvie Inc billboard -by Poetra_ RH via Shutterstock

How Is AbbVie's Stock Performance Compared to Other Pharmaceuticals Stocks? Barchart - Fri May 30, 6:29AM CDT

AbbVie has outperformed the Pharmaceuticals industry over the past year, and analysts are moderately optimistic about the stock’s prospects.

Are Wall Street Analysts Predicting AbbVie Stock Will Climb or Sink? Barchart - Wed May 7, 7:08AM CDT

AbbVie has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Gilead Sciences, Inc_ pills-by Marc Bruxelle via Shutterstock

What Are Wall Street Analysts' Target Price for Gilead Sciences Stock? Barchart - Mon May 5, 7:44AM CDT

Gilead Sciences has considerably outpaced the broader market over the past year, and Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Do Wall Street Analysts Like Pfizer Stock? Barchart - Thu May 1, 8:01AM CDT

Pfizer has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

More news for this symbol

Top 10 Holdings

Name	% Holdings
Eli Lilly and Company	5.44%
Abbvie Inc	5.23%
Johnson & Johnson	5.08%
Gilead Sciences Inc	4.89%
Merck & Company	4.81%
Amgen Inc	4.78%
Pfizer Inc	4.62%
Abbott Laboratories	4.51%
Travere Therapeutics Inc	4.40%
United Therapeutic	3.79%

3rd Resistance Point	109.87
2nd Resistance Point	109.13
1st Resistance Point	108.61
Last Price	108.08
1st Support Level	107.35
2nd Support Level	106.61
3rd Support Level	106.09

52-Week High	108.40
Last Price	108.08
Fibonacci 61.8%	94.59
Fibonacci 50%	90.33
Fibonacci 38.2%	86.06
52-Week Low	72.25

MAIN MENU

POPULAR

quotes

charts

technicals

options

options strategies

company